Zelira Therapeutics Limited (ZLD.AX)
AUD 0.62
(1.64%)
AUD 0.62
(1.64%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 1.25 Million AUD | -18.04% |
| 2023 | 1.52 Million AUD | -21.93% |
| 2022 | 1.95 Million AUD | 125.59% |
| 2021 | 867.58 Thousand AUD | 0.0% |
| 2020 | - AUD | 100.0% |
| 2019 | -33.06 Thousand AUD | 50.96% |
| 2018 | -67.42 Thousand AUD | 29.12% |
| 2017 | -95.12 Thousand AUD | -144.17% |
| 2016 | -38.95 Thousand AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | -100.0% |
| 2009 | 1200.00 AUD | 0.0% |
| 2008 | 1200.00 AUD | -99.97% |
| 2007 | 4.25 Million AUD | 1066.93% |
| 2006 | 364.98 Thousand AUD | 45.99% |
| 2005 | 250 Thousand AUD | 0.0% |
| 2004 | 250 Thousand AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q4 | 1.25 Million AUD | 0.0% |
| 2024 Q2 | 1.39 Million AUD | 0.0% |
| 2024 FY | 1.25 Million AUD | -18.04% |
| 2023 FY | 1.52 Million AUD | -21.93% |
| 2023 Q2 | 1.7 Million AUD | 0.0% |
| 2023 Q4 | 1.52 Million AUD | 0.0% |
| 2022 Q2 | 1.04 Million AUD | 0.0% |
| 2022 Q4 | 1.95 Million AUD | 0.0% |
| 2022 FY | 1.95 Million AUD | 125.59% |
| 2021 Q2 | 299.43 Thousand AUD | 0.0% |
| 2021 Q4 | 867.58 Thousand AUD | 0.0% |
| 2021 FY | 867.58 Thousand AUD | 0.0% |
| 2020 Q2 | - AUD | 0.0% |
| 2020 FY | - AUD | 100.0% |
| 2020 Q4 | - AUD | 0.0% |
| 2019 FY | -33.06 Thousand AUD | 50.96% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q4 | -33.06 Thousand AUD | 0.0% |
| 2018 Q4 | -91.08 Thousand AUD | 0.0% |
| 2018 FY | -67.42 Thousand AUD | 29.12% |
| 2018 Q2 | - AUD | 0.0% |
| 2017 FY | -95.12 Thousand AUD | -144.17% |
| 2017 Q4 | -99.3 Thousand AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2016 Q4 | -38.95 Thousand AUD | 0.0% |
| 2016 FY | -38.95 Thousand AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | -100.0% |
| 2009 Q4 | 1200.00 AUD | 0.0% |
| 2009 FY | 1200.00 AUD | 0.0% |
| 2008 FY | 1200.00 AUD | -99.97% |
| 2008 Q4 | 1200.00 AUD | 0.0% |
| 2007 FY | 4.25 Million AUD | 1066.93% |
| 2007 Q4 | 4.25 Million AUD | 0.0% |
| 2006 FY | 364.98 Thousand AUD | 45.99% |
| 2006 Q4 | 364.98 Thousand AUD | 0.0% |
| 2005 FY | 250 Thousand AUD | 0.0% |
| 2005 Q4 | 250 Thousand AUD | 0.0% |
| 2004 FY | 250 Thousand AUD | 0.0% |
| 2004 Q4 | 250 Thousand AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 1.4 Million AUD | 10.626% |
| Anatara Lifesciences Ltd | -671.09 Thousand AUD | 286.608% |
| Biome Australia Limited | 1.88 Million AUD | 33.69% |
| Patrys Limited | - AUD | -Infinity% |
| Orthocell Limited | 1.17 Million AUD | -6.431% |
| Imugene Limited | - AUD | -Infinity% |
| Noxopharm Limited | -2.35 Million AUD | 153.081% |
| PYC Therapeutics Limited | -17.99 Million AUD | 106.959% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | - AUD | -Infinity% |
| Proteomics International Laboratories Limited | - AUD | -Infinity% |
| Cynata Therapeutics Limited | 108.2 Thousand AUD | -1057.361% |
| CSL Limited | 8.93 Billion AUD | 99.986% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 10.62 Million AUD | 88.215% |
| Starpharma Holdings Limited | 2.4 Million AUD | 47.994% |
| Nanollose Limited | - AUD | -Infinity% |
| Memphasys Limited | 164.76 Thousand AUD | -660.077% |
| Invex Therapeutics Ltd | -94.98 Thousand AUD | 1418.458% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | - AUD | -Infinity% |
| Botanix Pharmaceuticals Limited | 1.2 Million AUD | -3.55% |
| Island Pharmaceuticals Limited | -877.24 Thousand AUD | 242.756% |
| Race Oncology Limited | 16.4 Thousand AUD | -7535.577% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 17.31 Million AUD | 92.765% |
| Dimerix Limited | - AUD | -Infinity% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 2.00 AUD | -62615450.0% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 1.00 AUD | -125231000.0% |
| BTC Health Limited | - AUD | -Infinity% |
| Acrux Limited | 147 Thousand AUD | -751.912% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Biotron Limited | - AUD | -Infinity% |
| Tissue Repair Ltd | 214.72 Thousand AUD | -483.224% |
| AdAlta Limited | -1.67 Million AUD | 174.564% |
| Radiopharm Theranostics Limited | -987.41 Thousand AUD | 226.827% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 221.85 Thousand AUD | -464.468% |
| Paradigm Biopharmaceuticals Limited | - AUD | -Infinity% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 97.11 Thousand AUD | -1189.487% |
| Actinogen Medical Limited | 108.82 Thousand AUD | -1050.714% |
| Immuron Limited | 1.58 Million AUD | 20.97% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |